Your browser doesn't support javascript.
Machine learning of COVID-19 clinical data identifies population structures with therapeutic potential.
Greenwood, David; Taverner, Thomas; Adderley, Nicola J; Price, Malcolm James; Gokhale, Krishna; Sainsbury, Christopher; Gallier, Suzy; Welch, Carly; Sapey, Elizabeth; Murray, Duncan; Fanning, Hilary; Ball, Simon; Nirantharakumar, Krishnarajah; Croft, Wayne; Moss, Paul.
  • Greenwood D; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Taverner T; The Centre for Computational Biology, University of Birmingham, Birmingham, UK.
  • Adderley NJ; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Price MJ; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Gokhale K; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Sainsbury C; NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK.
  • Gallier S; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Welch C; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Sapey E; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Murray D; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
  • Fanning H; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Ball S; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
  • Nirantharakumar K; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Croft W; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
  • Moss P; Health Data Research, London, UK.
iScience ; 25(7): 104480, 2022 Jul 15.
Article in English | MEDLINE | ID: covidwho-1867295
ABSTRACT
Clinical outcomes for patients with COVID-19 are heterogeneous and there is interest in defining subgroups for prognostic modeling and development of treatment algorithms. We obtained 28 demographic and laboratory variables in patients admitted to hospital with COVID-19. These comprised a training cohort (n = 6099) and two validation cohorts during the first and second waves of the pandemic (n = 996; n = 1011). Uniform manifold approximation and projection (UMAP) dimension reduction and Gaussian mixture model (GMM) analysis was used to define patient clusters. 29 clusters were defined in the training cohort and associated with markedly different mortality rates, which were predictive within confirmation datasets. Deconvolution of clinical features within clusters identified unexpected relationships between variables. Integration of large datasets using UMAP-assisted clustering can therefore identify patient subgroups with prognostic information and uncovers unexpected interactions between clinical variables. This application of machine learning represents a powerful approach for delineating disease pathogenesis and potential therapeutic interventions.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Journal: IScience Year: 2022 Document Type: Article Affiliation country: J.isci.2022.104480

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Journal: IScience Year: 2022 Document Type: Article Affiliation country: J.isci.2022.104480